Artia Global Partners »

Insmed shares owned by Artia Global Partners

Quarter-by-quarter ownership of Insmed (INSM) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Insmed

Tip: Access up to 7 years of quarterly data

All positions including Insmed held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Insmed by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.3M 75k 30.99

More positions owned by Artia Global Partners

Novo-nordisk A S Adr (NVO)
Eli Lilly & Co. (LLY)
Merck & Co (MRK)
Cytokinetics Call Call Option
Cytokinetics Put Put Option
Eli Lilly & Co Put Put Option
Abbvie (ABBV)
Argenx Se Sponsored Adr (ARGX)
Astrazeneca Sponsored Adr (AZN)
Viking Therapeutics (VKTX)
Axsome Therapeutics (AXSM)
Neurocrine Biosciences (NBIX)
Intra Cellular Therapies (ITCI)
BioMarin Pharmaceutical (BMRN)
Cytokinetics Com New (CYTK)

View all positions for Artia Global Partners

Top funds holding Insmed

Vanguard Group
T. Rowe Price Associates
Palo Alto Investors
William Blair Investment Management
Franklin Resources
Bellevue Group
Alliancebernstein
Bank of New York Mellon
Holocene Advisors
Millennium Management
Balyasny Asset Management
Norges Bank Investment Management
Marshall Wace
Principal Financial Group
Henderson Group

View all funds holding Insmed